Clinical Trials Browser

Phase 2 × Terminated × relatlimab × Clear all

NCT03724968 2021-04-20

Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression

Phase 2 Terminated

2 enrolled 6 charts

Melanoma

NCT02750514 2021-03-22

FRACTION-Lung

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer